Roth KS, Segal S.Tubular aspects of hereditary and developmental disorders of the kidney. In: Hamburger J, ed. Nephrology . New York: Wiley and Sons, 1979;945-75.
2.
Wollaston WHOn cystic oxide, a new species of urinary calculus . Philos Trans R Soc Lond1810;100:223-30.
3.
Garrod AEThe Croonian Lectures. Lancet1908;2:1-7.
4.
Dent CE, Rose GAAmino acid metabolism in cystinuria. Q J Med1981;20:205-19.
5.
McNamara PD, Pepe LM, Segal S.Cystine uptake by rat renal brush border vesicles. Biochem J1981; 194:443-9.
6.
Kato T.Renal transport of lysine and arginine in cystinuria. Tohoku J Exp Med1983;139:9-16.
7.
Cohn RM, Roth KSMetabolic Diseases: A Guide to Early Recognition. Philadelphia : W. B. Saunders, 1982;253-5.
8.
Roth KS, Buckalew VM, Chan Jcm.Renal tubular disorders. In: Gonick HC, ed. Current Nephrology. Chicago: Year Book, 1985;8:87-137.
9.
Dahlberg PJ, Van Den Berg CJ, Kurtz CB, et al. Clinical features and management of cystinuria. Mayo Clin Proc1977;52:533-42.
10.
Halperin EC, Thier SO, Rosenberg LEThe use of D-penicillamine in cystinuria: Efficacy and untoward reactions . Yale J Biol Med1981;54:439-46.
11.
Zechner O., Latal D., Grundig E., et al. Klinische aspekte der cystinurie und ihre behandlung mit thiola . Wiener Klin Wochenscher1976;88:101-5.
12.
Jaeger P., Portmann L., Saunders A., et al. Anticystinuric effects of glutamine and of dietary sodium restriction . N Engl J Med1986;315:1120-3.
13.
Wrong O., Davies Hef.The excretion of acid in renal disease. Q J Med1959;28:259-67.
14.
Norman ME, Feldman NI, Cohn RM, et al. Urinary citrate excretion in familial incomplete distal renal tubular acidosis. J Pediatr1978;92:394-400.
15.
Loney L., Norling LL, Robson AMThe use of arginine hydrochloride infusion to assess urinary acidification . J Pediatr1982;100:95-8.
16.
Rodriquez-Soriano J., Vallo A., Castillo G., et al. Natural history of primary distal renal tubular acidosis treated since infancy. J Pediatr1982;101:669-76.
17.
Stanbury JB, Wyngarden JB, Fredrickson DS, et al. TheMetabolic Basis of Inherited Disease. New York: McGraw-Hill, 1983.
18.
Brewer GJ, Hill GM, Prasad AS, et al. Oral zinc therapy for Wilson's disease. Ann Intern Med1983;99:314-20.
19.
Scheinberg IH, Jaffe ME, Sternlief I.The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med1987;317:209-13.
20.
Baron DN, Dent CE, Harris H., et al. Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal aminoaciduria, and other bizarre biochemical features . Lancet1956;1:421-8.
21.
Milne MD, Crawford MA, Girao CB, et al. The metabolic disorder in Hartnup disease. Q J Med1960;29:407-14.
